Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dextrose + sodium chloride (Koçak) is an intravenous solution produced by Koçak Farma, a Turkish generic pharmaceutical manufacturer. This combination product consists of dextrose (a monosaccharide) and sodium chloride (an electrolyte), formulated for parenteral administration. It is primarily used for fluid and electrolyte replacement and to provide a source of calories through glucose supplementation. Dextrose provides metabolic energy and helps prevent ketosis by minimizing liver glycogen depletion, while sodium chloride maintains osmotic pressure and replaces essential sodium and chloride ions lost through dehydration or other clinical conditions. The product is an approved generic solution used in hospital settings for patients requiring intravenous hydration and nutritional support.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dextrose + sodium chloride (Koçak).